Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bin Qi Gan
Observed name:
Bin Gan
Institutions:
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University
Observed institutions:
National University of Singapore,
Guangdong General Hospital,
Guangdong Academy of Medical Sciences,
National University Health System,
Guangdong Provincial People's Hospital,
Southern Medical University,
Institute of Molecular and Cell Biology
show all 7
ORCID:
0000-0001-5489-663X
Observed ORCID:
0000-0001-5489-663X
OpenAlex ID:
A5081199145
Involvement of members of the Rab family and related small GTPases in autophagosome formation and maturation
2011
·
Christelle En Lin Chua
, Bin Qi Gan
, et al.
·
Cellular and Molecular Life Sciences
·
146
VAMP8/Endobrevin as a General Vesicular SNARE for Regulated Exocytosis of the Exocrine System
2007
·
Cheng-Chun Wang
, Hong Shi
, et al.
·
Molecular Biology of the Cell
·
112
Catalytic domain of PRL-3 plays an essential role in tumor metastasis: Formation of PRL-3 tumors inside the blood vessels
2004
·
Ke Guo
, Jie Li
, et al.
·
Cancer Biology & Therapy
·
104
PDF
Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non–Small Cell Lung Cancer
2017
·
Anna Li
, Jin-ji Yang
, et al.
·
Clinical Cancer Research
·
102
PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo
2006
·
Ke Guo
, Jie Li
, et al.
·
Cancer Research
·
102
Generation of PRL-3- and PRL-1-Specific Monoclonal Antibodies as Potential Diagnostic Markers for Cancer Metastases
2005
·
Jie Li
, Ke Guo
, et al.
·
Clinical Cancer Research
·
70
Rab GTPases regulating receptor trafficking at the late endosome–lysosome membranes
2012
·
Ee Ling Ng
, Bin Qi Gan
, et al.
·
Cell Biochemistry and Function
·
50
Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial
2019
·
Yi-Chen Zhang
, Zhi-Hong Chen
, et al.
·
EBioMedicine
·
47
PDF
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
2023
·
Si-Yang Maggie Liu
, Jie Huang
, et al.
·
中国科学通报:英文版
·
41
Syntaxin 16: Unraveling cellular physiology through a ubiquitous SNARE molecule
2010
·
Yanan Chen
, Bin Qi Gan
, et al.
·
Journal of Cellular Physiology
·
29
Abstract CT127: A phase I study of cMET inhibitor bozitinib in patients with advanced NSCLC harboring cMET alterations
2020
·
Jinji Yang
, Qing Zhou
, et al.
·
Cancer Research
·
26
Syntaxin 9 is Enriched in Skin Hair Follicle Epithelium and Interacts With the Epidermal Growth Factor Receptor
2005
·
Ya Wang
, Ling Yann Foo
, et al.
·
Traffic
·
17
PDF
Sirt1’s beneficial roles in neurodegenerative diseases – a chaperonin containing TCP‐1 (CCT) connection?
2010
·
Bin Qi Gan
, Bor Luen Tang
·
Aging Cell
·
12
The safety profile of a selective EGFR TKI epitinib (HMPL-813) in patients with advanced solid tumors and preliminary clinical efficacy in EGFRm+ NSCLC patients with brain metastasis.
2016
·
Qing Zhou
, Bin Gan
, et al.
·
Journal of Clinical Oncology
·
7
[Efficacies of gefitinib versus paclitaxel/carboplatin for patients with advanced pulmonary adenocarcinoma].
2014
·
Nana Lou
, Jinji Yang
, et al.
·
PubMed
·
6
Incidence and risk factors for hypoglycemia in patients with hepatocellular carcinoma
2021
·
XiaoJing Zheng
, Hong-Hong Yan
, et al.
·
Research Square
·
3
PDF
[An Overview and Interpretation of Important Clinical Studies on Non-small Cell Lung Cancer in 2021].
2022
·
Bin Gan
, Siyang Liu
, et al.
·
PubMed Central
·
2
PDF
CLUSTER: A biomarker-integrated targeted therapy study in patients with advanced non-small cell lung cancer
2022
·
Qing Zhou
, Hua-Jun Chen
, et al.
·
Research Square
·
2
PDF
CLUSTER: A biomarker-integrated targeted therapy study in patients with advanced non-small cell lung cancer
2022
·
Qing Zhou
, Hua-Jun Chen
, et al.
·
Research Square
·
1
JCES01.17 A Phase I Dose Expansion Study of Epitinib to Evaluate Efficacy and Safety in EGFR Mutation Positive (EGFRm+) NSCLC Patients with Brain Metastasis
2017
·
Qing Zhou
, Bin Gan
, et al.
·
Journal of Thoracic Oncology
·
1
Supplementary Figures 1-4 from PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo
2023
·
Ke Guo
, Jie Li
, et al.
PDF
Supplementary Serial Section 2 from PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo
2023
·
Ke Guo
, Jie Li
, et al.
Data from PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo
2023
·
Ke Guo
, Jie Li
, et al.
Supplementary Serial Section 3 from PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo
2023
·
Ke Guo
, Jie Li
, et al.
Supplementary Serial Section 1 from PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo
2023
·
Ke Guo
, Jie Li
, et al.
Show more works
View as search
Works count:
31
Citation count:
880
H-index:
12
I10-index:
13
Year
Topic
Type